A Trial of Dexmedetomidine Hydrochloride Nasal Spray in Preoperative Sedation of Children

PHASE3CompletedINTERVENTIONAL
Enrollment

159

Participants

Timeline

Start Date

November 24, 2021

Primary Completion Date

May 20, 2022

Study Completion Date

May 20, 2022

Conditions
Preoperative Sedation of Children
Interventions
DRUG

Dexmedetomidine Hydrochloride Nasal Spray

"In the low weight group, the subjects will receive a low dose of dexmedetomidine nasal spray.~In the high weight group, the subjects will receive a high dose of dexmedetomidine nasal spray."

DRUG

Dexmedetomidine hydrochloride nasal spray blank preparation

"In the low weight group, the subjects will receive dexmedetomidine hydrochloride nasal spray blank preparation.~In the high weight group, the subjects will receive dexmedetomidine hydrochloride nasal spray blank preparation."

Trial Locations (1)

100045

Beijing Children's Hospital Affiliated to Capital Medical University, Beijing

All Listed Sponsors
lead

Shanghai Hengrui Pharmaceutical Co., Ltd.

INDUSTRY

NCT05111431 - A Trial of Dexmedetomidine Hydrochloride Nasal Spray in Preoperative Sedation of Children | Biotech Hunter | Biotech Hunter